CHO Pharma, Inc. (TPEX:6586)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
26.50
+0.05 (0.19%)
Feb 11, 2026, 1:53 PM CST
Market Cap5.66B -47.4%
Revenue (ttm)3.21M +196.7%
Net Income-230.38M
EPS-1.08
Shares Out214.01M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume313,935
Average Volume385,905
Open26.45
Previous Close26.45
Day's Range25.90 - 27.15
52-Week Range25.80 - 64.70
Beta-0.51
RSI35.29
Earnings DateMar 23, 2026

About CHO Pharma

CHO Pharma, Inc., engages in research and development of biotechnology in Taiwan. It develops glycoengineering platform technologies, including SAR-based glycoengineered biobetters; glycosite-specific antibody-drug conjugates (ADCs); novel antibodies and vaccines targeting novel carbohydrate antigens; and programs using its glycoengineering technologies. The company also provides CHOptimax, an in vitro enzymatic one-pot process that converts naked antibodies into glycoengineered biobetter or ADC. In addition, the company develops CHO-H01, which... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6586
Full Company Profile

Financial Performance

Financial Statements